Reviva Pharmaceuticals (RVPH) Institutional Ownership $1.03 -0.02 (-1.90%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.03 +0.00 (+0.49%) As of 05/23/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)CurrentInstitutional OwnershipPercentage63.18%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$1.05MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.06M Get RVPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RVPH Institutional Buying and Selling by Quarter Reviva Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 NewEdge Advisors LLC60,900$58K0.0%N/A0.130% 5/5/2025 Private Advisor Group LLC200,000$191K0.0%N/A0.428% 5/2/2025 BluePointe Capital Management LLC47,185$45K0.0%+354.7%0.101% 2/17/2025 Tang Capital Management LLC170,000$308K0.0%N/A0.508% 2/17/2025 Millennium Management LLC1,804,488$3.27M0.0%-1.5%5.396% 2/17/2025 Focus Partners Wealth60,000$109K0.0%-62.7%0.179% 2/17/2025 Cornerstone Select Advisors LLC17,500$32K0.0%N/A0.052% 2/17/2025 Ameriprise Financial Inc.46,467$84K0.0%N/A0.139% 2/14/2025 Schonfeld Strategic Advisors LLC1,058,100$1.92M0.0%-30.2%3.164% 2/14/2025 Tower Research Capital LLC TRC26,775$48K0.0%+848.8%0.080% Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025 XTX Topco Ltd25,020$45K0.0%N/A0.075% 2/13/2025 Raymond James Financial Inc.14,000$25K0.0%N/A0.042% 2/12/2025 Geode Capital Management LLC311,701$564K0.0%+11.9%0.932% 2/6/2025 Raymond James Financial Inc.14,000$25K0.0%N/A0.042% 1/23/2025 EMC Capital Management44,535$81K0.0%+142.0%0.133% 1/22/2025 Drive Wealth Management LLC20,000$36K0.0%N/A0.060% 11/16/2024 Geode Capital Management LLC278,496$401K0.0%+17.9%0.833% 5/10/2024 Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588% 2/13/2024 Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318% 1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062% 11/15/2023 Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649% 11/9/2023 EMC Capital Management123,915$613K0.4%+1,294.3%0.547% 8/7/2023 Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071% 7/27/2023 Virtu Financial LLC18,448$108K0.0%N/A0.090% 2/15/2023 Tang Capital Management LLC24,125$103K0.0%N/A0.118% 2/13/2023 EMC Capital Management123,915$527K0.5%+125.0%0.606% 2/1/2023 Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033% 11/7/2022 Virtu Financial LLC46,119$73K0.0%N/A0.226% 10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161% 2/10/2022 EMC Capital Management55,078$159K0.1%-27.4%0.364% 2/3/2022 Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067% 11/9/2021BlackRock Inc.33,470$136K0.0%+82.7%0.241% 8/17/2021 Armistice Capital LLC714,700$3.47M0.1%N/A7.742% 8/13/2021 Renaissance Technologies LLC11,250$55K0.0%N/A0.122% 8/13/2021 Northern Trust Corp10,584$51K0.0%N/A0.115% 8/13/2021 Geode Capital Management LLC67,724$329K0.0%N/A0.734% 8/13/2021 Vanguard Group Inc.529,464$2.57M0.0%N/A5.735% 7/28/2021 DAVENPORT & Co LLC10,000$49K0.0%-33.3%0.108% 5/21/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397% 5/18/2021 Millennium Management LLC35,310$203K0.0%N/A0.382% $19 for a FULL YEAR of stock picks?! (Ad)Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.Watch the exclusive AI investor briefing >>>5/18/2021 Citadel Advisors LLC36,652$210K0.0%N/A0.397% (Data available from 1/1/2016 forward) RVPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RVPH shares? During the previous two years, 20 institutional investors and hedge funds held shares of Reviva Pharmaceuticals. The most heavily invested institutionals were Armistice Capital LLC ($9.09M), Vanguard Group Inc. ($3.79M), Millennium Management LLC ($3.27M), Schonfeld Strategic Advisors LLC ($1.92M), Geode Capital Management LLC ($564K), Tang Capital Management LLC ($308K), and Private Advisor Group LLC ($191K).Learn more on RVPH's institutional investors. What percentage of Reviva Pharmaceuticals stock is owned by institutional investors? 63.18% of Reviva Pharmaceuticals stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings. Which institutional investors have been buying Reviva Pharmaceuticals stock? Of the 17 institutional investors that purchased Reviva Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.16M), Private Advisor Group LLC ($200K), Tang Capital Management LLC ($170K), EMC Capital Management ($141.16K), Geode Capital Management LLC ($75.58K), NewEdge Advisors LLC ($60.90K), and Ameriprise Financial Inc. ($46.47K). How much institutional buying is happening at Reviva Pharmaceuticals? Institutional investors have bought a total of 2,077,089 shares in the last 24 months. This purchase volume represents approximately $7.94M in transactions. Which Reviva Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Schonfeld Strategic Advisors LLC ($457.80K), Armistice Capital LLC ($224K), Focus Partners Wealth ($101K), and Millennium Management LLC ($28.33K). How much institutional selling is happening at Reviva Pharmaceuticals? Institutional investors have sold a total of 811,126 shares in the last 24 months. This volume of shares sold represents approximately $2.16M in transactions. Related Companies SLS Major Shareholders FTLF Major Shareholders NKTX Major Shareholders CYBN Major Shareholders TNGX Major Shareholders EPRX Major Shareholders ACRS Major Shareholders ADCT Major Shareholders LRMR Major Shareholders EDIT Major Shareholders This page (NASDAQ:RVPH) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
